Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In health economics and outcomes research (HEOR) and epidemiologic studies, claims data alone leave researchers without essential information such as: Body mass index (BMI) or weight trajectory to identify obesity thresholds or track improvement A1c and lipid panels to assess cardiometabolic change Liver and kidney markers such as ALT, AST, and eGFR to evaluate comorbidities like MASH or nephropathy Physician notes that document adherence barriers, recommended dosing schedules, or dietary guidance These gaps in claims mean that researchers are missing many aspects of the patient journey (Figure 1)
It is not authorized under the Food and Drugs Act, does not carry a Drug Identification Number (DIN), Natural Product Number (NPN), or Homeopathic Drug Number (DIN-HM) issued by Health Canada, and is not intended to diagnose, treat, cure, or prevent any disease
CM: Conceptualization, Supervision, Validation, Writing original draft, Writing review and editing
Daily drive to keep your metabolism cranking without the sweats
Patients with favorable genetic profiles for sustained GLP-1 response often experience durable weight loss and improved metabolic markers over years of continuous treatment
Circular RNAs as novel regulators of -cell functions in normal and disease conditions
US$ 23.63
US$ 25.47
&srotate=0)
US$ 23.04
US$ 27.86
US$ 25.71
